Companys expansion of its domestic footprint.
2026 · 3rd Quarter (July 1 - Sep 30)
ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS
Filed by BROWNSTEIN HYATT FARBER SCHRECK, LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 16, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Filing UUID
- 4fddddce-9b5f-47cd-a80d-b87c71f07ea3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry Drug pricing issues
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.